Skip to content

Edwards Lifesciences EW Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin312.9%-5.4pp314.6%-3.8pp316%-1.2pp317.6%-2.2pp318.3%-4.4pp
Operating margin92.3%-12.8pp96.7%-8.5pp101.2%-5.9pp103.5%-6.1pp105.1%-6.6pp
Net margin131.3%-128pp189.6%-21.2pp248.7%+86.6pp303.6%+185pp258.9%+136pp
Returns
Return on equity81.3%-90.0pp119%-25.4pp158.6%+41.8pp196.1%+108pp171.3%+82.4pp
Return on invested capital61%-15.8pp65.1%-13.0pp69.8%-10.6pp73.9%-4.6pp76.8%-0.4pp
Efficiency
Asset turnover1.9×-0.1×1.9×-0.2×1.9×-0.2×1.9×-0.2×-0.1×
Liquidity
Current ratio16.8×+1.0×16.9×+1.8×17.3×+3.0×16.8×+2.6×15.8×+2.2×
Leverage
Debt-to-equity0.3×0.0×0.3×-0.1×0.3×-0.1×0.3×-0.1×0.3×-0.1×
Net debt / EBITDA-5.6×0.0×-6×-1.6×-5.9×-2.8×-6.6×-4.8×-5.6×-4.1×
Per Share
Book value per share$70.79+13.8%$70.24+23.8%$69.28+35.9%$67.81+47.7%$62.18+41.1%
Valuation
Market capitalization$185.79B+2.3%$182.08B-7.4%$176.27B-11.5%$170.36B-15.5%$181.53B-10.6%
Price / earnings132.3×+64.3×100.3×+1.9×64.7×-56.3×40.9×-100.0×68×-76.3×
Price / sales31.1×-2.8×31.4×-6.0×31.3×-7.3×31×-10.2×33.9×-10.1×
Price / book17.9×-2.3×17.7×-6.4×17.3×-9.4×16.9×-11.9×20.2×-10.1×
EV / EBITDA116.2×+5.7×112.1×-11.7×105.7×-21.4×101.7×-32.4×110.4×-29.8×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Edwards Lifesciences's profit margins?
Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.
Where do Edwards Lifesciences's ratios come from?
Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.